Study guide
12.3 Urology & Men's Health
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
12.3 Urology & Men's Health
Key Takeaways Explain This Topic AI
Anyone taking or who has taken an alpha-1 blocker such as tamsulosin must tell the ophthalmologist before cataract surgery because of intraoperative floppy iris syndrome.
Finasteride and dutasteride reduce PSA by roughly half, so a PSA measured during therapy must be interpreted accordingly, and take 3-6 months for meaningful benefit.
AMH advises avoiding nitrofurantoin below an eGFR of about 45 mL/min, and it must not be used for pyelonephritis or urosepsis or near term in pregnancy.
Urinary alkalinisers must not be combined with nitrofurantoin because alkaline urine reduces its antibacterial activity.
PDE5 inhibitors are absolutely contraindicated with nitrates in any form and with riociguat because of catastrophic hypotension.
Last updated: August 2026
12.3 Urology & Men's Health
Quick Answer: APC names urological conditions as exam content. Community-relevant material is benign prostatic hyperplasia medicines (alpha blockers and 5-alpha reductase inhibitors), overactive bladder and anticholinergic burden, urinary tract infection selection rules including nitrofurantoin's renal limits, and erectile dysfunction medicines with their absolute nitrate contraindication.
Benign prostatic hyperplasia (BPH)
Lower urinary tract symptoms in older men — hesitancy, weak stream, nocturia, incomplete emptying — are common and mostly manageable, but they overlap with conditions that must not be missed.
Alpha-1 blockers (tamsulosin, prazosin, silodosin, alfuzosin)
Work within days to weeks by relaxing prostatic and bladder-neck smooth muscle; they relieve symptoms without changing prostate size
Postural hypotension and first-dose effect — counsel to take at night, rise slowly, and be careful with the first dose or after a dose increase
Additive hypotension with antihypertensives and with PDE5 inhibitors
Intraoperative floppy iris syndrome — anyone taking or who has taken an alpha blocker must tell the ophthalmologist before cataract surgery . This is the single most examinable tamsulosin counselling point.
Abnormal ejaculation is common with tamsulosin and silodosin, and is a frequent silent reason for non-adherence — raise it sensitively
5-alpha reductase inhibitors (finasteride, dutasteride)
Shrink the prostate over time; expect 3–6 months before meaningful benefit — set that expectation or the patient will stop early
Reduce PSA by roughly half. A PSA measured during therapy must be interpreted with that in mind, typically by doubling it. Failing to account for this can hide prostate cancer.
Sexual adverse effects (reduced libido, erectile dysfunction, ejaculatory changes) and breast changes; report breast lumps
Handling caution: women who are or may become pregnant should not handle crushed or broken finasteride tablets or leaking dutasteride capsules because of the risk to a male fetus
Blood donation is generally deferred during and for a period after treatment
Combination alpha blocker plus 5-alpha reductase inhibitor is used for larger prostates with a view to reducing progression.
Refer, do not manage, when you see
Acute urinary retention, visible haematuria, fever with urinary symptoms, unexplained weight loss or bone pain, a rapidly worsening stream, or any first presentation without a medical assessment.
Overactive bladder
Class Examples Key pharmacist points
Antimuscarinics Oxybutynin, solifenacin, darifenacin Dry mouth, constipation, blurred vision, urinary retention; cognitive impairment and falls in older people ; caution in narrow-angle glaucoma
Beta-3 agonist Mirabegron Alternative when anticholinergic burden is a problem; monitor blood pressure
Anticholinergic burden is a genuine deprescribing concern. An older patient already on a sedating antihistamine, a tricyclic and an antipsychotic does not need oxybutynin added without review. Non-drug measures — bladder training, caffeine and alcohol reduction, pelvic floor exercises, timed voiding, and reviewing diuretic timing — come first and are examinable in their own right.
- Urinary tract infection
- Who can be managed and who must be referred
Presentation Action
Uncomplicated cystitis, non-pregnant adult woman Short-course antibiotic therapy under the relevant prescribing or supply pathway; symptomatic advice
- UTI symptoms in a man Refer — treated as complicated
- Pregnancy Refer; asymptomatic bacteriuria is treated in pregnancy
- Children Refer
- Fever, loin pain, rigors, vomiting Suspected pyelonephritis — urgent medical assessment
- Recurrent or treatment-failure infections Medical review, not repeated OTC cycles
- Agent-specific traps
Nitrofurantoin — efficacy depends on renal secretion into urine, so it fails as renal function falls. AMH advises avoiding it below an eGFR of about 45 mL/min , with short courses used cautiously in the 30–44 range only for resistant lower urinary tract infection; note that some Australian product information still carries the older creatinine clearance of 60 mL/min contraindication. Check AMH in the exam rather than reciting one number. It may be used for cystitis in pregnancy but is avoided near term (from about 38 weeks) because of neonatal haemolysis risk. It does not treat upper urinary tract infection or urosepsis.
Trimethoprim — a folate antagonist, so it is avoided in the first trimester; watch for hyperkalaemia risk with ACE inhibitors, ARBs, spironolactone and potassium supplements, and interaction with methotrexate.
Urinary alkalinisers — commonly requested for symptom relief, but they should not be combined with nitrofurantoin because alkaline urine reduces its activity. Also unsuitable for people on sodium- or potassium-restricted diets depending on the product.
Cranberry products — evidence for prevention is weak, they do not treat an established infection, and they interact with warfarin.
Erectile dysfunction
PDE5 inhibitors are absolutely contraindicated with nitrates in any form — glyceryl trinitrate tablets, spray or patches, and isosorbide preparations — because of catastrophic hypotension. Also contraindicated with riociguat .
Additive hypotension with alpha blockers means timing and dose care.
Some sildenafil presentations are available as Pharmacist Only (Schedule 3) medicines under strict pharmacist assessment criteria; product scheduling changes, so confirm the current Poisons Standard entry and your jurisdiction's rules rather than memorising a pack.
Erectile dysfunction can be an early marker of cardiovascular disease and diabetes. A man presenting for the first time deserves a cardiovascular conversation and medical review, not just a supply.
Sudden vision or hearing loss during therapy requires immediate medical attention; an erection lasting more than four hours is a medical emergency.
Medicines can cause the problem: thiazides, beta-blockers, SSRIs, finasteride and antipsychotics are common contributors and are worth reviewing before adding therapy.
Exam mindset
Urology stems test whether you can spot the referral trigger inside a routine request. Cataract surgery plus tamsulosin, a PSA result on finasteride, nitrofurantoin with a low eGFR, a nitrate patch with a request for sildenafil, and UTI symptoms in a man are all designed to see whether you check before you supply.
Screening, testosterone and the wider men's health conversation
Men present to pharmacies far less often than women, so the consultation you do get carries extra weight.
Prostate cancer screening is a shared decision, not a routine recommendation. PSA testing has real benefits and real harms (over-diagnosis and over-treatment), and eligibility discussions belong with the GP. Your role is to explain that the test exists, that a 5-alpha reductase inhibitor suppresses the result, and to encourage the conversation rather than to advise for or against testing.
Testosterone is a Schedule 4 medicine with PBS access restricted to defined clinical indications confirmed by pathology; it is not a treatment for ordinary ageing or tiredness. Counsel on application-site transfer risk for gels — cover the site, wash hands, and avoid skin contact with women and children — and on the need for ongoing monitoring including haematocrit and PSA.
Opportunistic conversations are legitimate practice: a man collecting a BPH medicine can reasonably be asked about blood pressure, smoking, alcohol and bowel screening participation. This links Standard 3.6 directly to a urological consultation.